Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness analyses alongside randomised clinical trials.

Alastair M Gray1

  • 1Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford, UK. alastair.gray@dphpc.ox.ac.uk

Clinical Trials (London, England)
|December 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial.

Journal of diabetes·2023
Same author

Health economic modeling for Alzheimer's disease: Expert perspectives.

Alzheimer's & dementia (New York, N. Y.)·2022
Same author

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double-blind, placebo-controlled trial.

Journal of diabetes·2022
Same author

Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial.

JAMA·2022
Same author

Clinical Manifestation and Diagnostic Process of Celiac Disease in Poland-Comparison of Pediatric and Adult Patients in Retrospective Study.

Nutrients·2022
Same author

Cost-Utility of an Online Education Platform and Diabetes Personal Health Record: Analysis Over Ten Years.

Journal of diabetes science and technology·2022
Same journal

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same journal

Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

Clinical trials (London, England)·2026
Same journal

Phase I design for partially ordered groups with late-onset toxicity.

Clinical trials (London, England)·2026
Same journal

Trial informed consent forms, the Declaration of Helsinki and the SPIRIT 2025 statement.

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Morning panel discussion).

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Afternoon panel discussion).

Clinical trials (London, England)·2026
See all related articles

Randomized controlled trials (RCTs) offer valuable patient-level data for health economists to assess cost-effectiveness. These trials provide unbiased estimates and support subgroup analysis, enhancing economic evaluations.

Area of Science:

  • Health Economics
  • Clinical Trial Analysis
  • Cost-Effectiveness Research

Background:

  • Growing advocacy among health economists for model-based evaluations over trial-based approaches.
  • Need to critically assess the utility of randomized controlled trials (RCTs) in economic evaluations.

Purpose of the Study:

  • To review the advantages and disadvantages of using RCT-based evaluations for cost-effectiveness analysis.
  • To inform health economists on the application of clinical trial data in economic modeling.

Main Methods:

  • Literature review focusing on the application of RCT data in health economic evaluations.
  • Analysis of large-scale studies (e.g., UKPDS, Heart Protection Study) to identify benefits of RCTs.

Main Results:

Related Experiment Videos

  • RCTs provide patient-level data, crucial for accurate cost-effectiveness estimation.
  • Advantages include unbiased resource use and effect estimates, subgroup analysis, and improved model building/validation.
  • Large randomized trials offer significant benefits for health economists.

Conclusions:

  • Patient-level data from clinical trials are essential for economic evaluations.
  • This data will continue to be a cornerstone of the health economics evidence base.
  • Clinical trial data will also drive methodological advancements in economic research.